留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x

青少年女性乳腺恶性叶状肿瘤内癌的临床病理诊断陷阱分析

秦艳 陈莹 周东华

秦艳, 陈莹, 周东华. 青少年女性乳腺恶性叶状肿瘤内癌的临床病理诊断陷阱分析[J]. 分子影像学杂志, 2018, 41(2): 229-232. doi: 10.3969/j.issn.1674-4500.2018.02.21
引用本文: 秦艳, 陈莹, 周东华. 青少年女性乳腺恶性叶状肿瘤内癌的临床病理诊断陷阱分析[J]. 分子影像学杂志, 2018, 41(2): 229-232. doi: 10.3969/j.issn.1674-4500.2018.02.21
Yan QIN, Ying CHEN, Donghua ZHOU. Traps in clinicopathologic diagnosis of malignant phyllodes tumor of the breast in adolescent female patients with intraductal carcinoma[J]. Journal of Molecular Imaging, 2018, 41(2): 229-232. doi: 10.3969/j.issn.1674-4500.2018.02.21
Citation: Yan QIN, Ying CHEN, Donghua ZHOU. Traps in clinicopathologic diagnosis of malignant phyllodes tumor of the breast in adolescent female patients with intraductal carcinoma[J]. Journal of Molecular Imaging, 2018, 41(2): 229-232. doi: 10.3969/j.issn.1674-4500.2018.02.21

青少年女性乳腺恶性叶状肿瘤内癌的临床病理诊断陷阱分析

doi: 10.3969/j.issn.1674-4500.2018.02.21
详细信息
    作者简介:

    秦艳:秦 艳,硕士,副主任医师,E-mail: qinyan8595@sina.com

Traps in clinicopathologic diagnosis of malignant phyllodes tumor of the breast in adolescent female patients with intraductal carcinoma

  • 摘要: 目的 分析青少年女性恶性叶状肿瘤内癌的诊断陷阱并进行文献复习。 方法 对1例青少年女性恶性叶状肿瘤内癌的临床特点、HE染色和免疫组化特点并结合文献进行分析。 结果 患者女性,18岁,镜下肿瘤细胞异型性十分明显,肿瘤增长速度快,易出现肿瘤坏死,在空芯针穿刺、冷冻及常规病理时,需排除纤维腺瘤和其他类型肉瘤、化生性癌等诊断,全面广泛取材及免疫组化才能做出准确的病理诊断。 结论 青少年女性乳腺恶性叶状肿瘤十分少见,恶性叶状肿瘤内癌更是十分罕见,提高该病临床病理特点的认识,可尽量减少误诊。

     

  • 图  1  手术标本

    A: 肿物空芯针穿刺(HE,×40); B, C, D: 恶性叶状肿瘤区域(HE,×40); E, F: 恶性叶状肿瘤内导管原位癌区域(HE,×40); G: 导管原位癌ER染色(EnVision法, ×40); H: 导管原位癌PR染色(EnVision法,×40).

  • [1] Rosen PP . Rosen's breast pathology[M]. New York: Lippin-Cott-Ray, 1996: 155-72.
    [2] RO Weller.The International histological classification of tumors[C]//World Health Organization, 1981,34(99): 555-74.
    [3] Tavassoli F, Devilee P. Pathology&genetics,tumours of the breast and female genital organs[M]. lyon: Larc Press, 2003.
    [4] Rosai J. Problems in breast pathology revisited preface[J].Semin Diagn Pathol, 2010, 27(1): 2-4. doi: 10.1053/j.semdp.2009.11.001
    [5] 丁华野, 张祥盛, 步 宏, 等. 乳腺病理诊断和鉴别诊断[M].北京: 人民卫生出版社, 2014: 264-6.
    [6] Abdul AM, Sullivan F, Kerin MJ, et al. Malignant phyllodes tumour with liposarcomatous differentiation,invasive tubular carcinoma and ductal and lobular carcinoma in situ:Case report and review of the literature[J]. Patholog Res Int, 2010,28(1): 501274-9.
    [7] Barrio AV, Clark BD, Goldberg JI, et al. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast[J]. Ann Surg Oncol, 2007, 14(10): 2961-70. doi: 10.1245/s10434-007-9439-z
    [8] Karim RZ, Scolyer RA, Tse GM, et al. Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours[J]. Pathology, 2009, 41(2): 105-17. doi: 10.1080/00313020802579342
    [9] Kwon JE, Jung WH, Koo JS. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis[J]. Tumour Biol, 2012, 33(3): 787-98. doi: 10.1007/s13277-011-0296-9
    [10] 金 华, 郭红红, 丁华野. 乳腺叶状肿瘤内的小叶瘤变及微小浸润癌临床病理观察[J]. 诊断病理学杂志, 2013, 20(09): 560-3. doi: 10.3969/j.issn.1007-8096.2013.09.016
    [11] Macher GS, Marme F, Goeppert B, et al. Invasive ductal breast cancer within a malignant phyllodes tumor:case report and assessment of clonality[J]. Hum Pathol, 2010, 41(2): 293-6. doi: 10.1016/j.humpath.2009.08.006
    [12] Jones AM, Mitter R, Springall R, et al. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence[J]. J Pathol, 2008, 214(5): 533-44. doi: 10.1002/path.v214:5
    [13] Muller KE, Tafe LJ, de Abreu FB, et al. Benign phyllodes tumorof the breast recurring as a malignant phyllodes tumor and spindle cell metaplastic carcinoma[J]. Hum Pathol, 2015, 46(2): 327-33. doi: 10.1016/j.humpath.2014.10.014
    [14] Hodges KB, Abdul KF, Wang M, et al. Evidence for nsformation of fibroadenoma of the breast to malignant phyllodes tumor[J]. Appl Immunohistoehem Mol Morphol, 2009, 17(4): 345-50. doi: 10.1097/PAI.0b013e318194d992
    [15] Ang MK, Ooi AS, Thike AA, et al. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression[J]. Breast Cancer Res Treat, 2011, 129(2): 319-29. doi: 10.1007/s10549-010-1204-5
    [16] Hirano H, Matsushita K, Okimura A, et al. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast[J]. Anticancer Res, 2014, 34(3, SI): 1251-3.
    [17] Burga AM, Tavassoli F. Periducttal stromal tumor:a rare lesion with low-grade sarcomatous behavior[J]. Am J Surg Pathol, 2003, 27(9): 343-8.
    [18] Liang MI, Ramaswamy B, Patterson CC, et al. Giant breast tumors: Surgical management of phyllodes tumors, potential for reconstructive surgery and a review of literature[J]. World J Surg Oncol, 2008, 6(9): 117-24.
    [19] Jang JH, Choi MY, Lee SK, et al. Clinicopathologic risk factors for the local recurrence of phyllodes tumors of the breast[J]. Ann Surg Oncol, 2012, 19(8): 2612-7. doi: 10.1245/s10434-012-2307-5
    [20] Macdonald OK, Lee CM, Tward JD, et al. Malignant phyllodes tumor of the female breast:association of primary therapy causespecific survival from the Surveillance,Epidemiology,and End Results(SEER)program[J]. Cancer, 2006, 107(9): 2127-33. doi: 10.1002/(ISSN)1097-0142
    [21] Barth RJ, Wells WA, Mitchell SE, et al. A prospective,multiinstitutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors[J]. Ann Surg Oncol, 2009, 16(8): 2288-94. doi: 10.1245/s10434-009-0489-2
    [22] Wei J, Tan YT, Cai YC, et al. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center[J]. Chin J Cancer, 2014, 33(10): 492-500.
    [23] Lenhard MS, Kahlert S, Himsl I, et al. Phyllodes tumour of the breast: Clinical follow-up of 33 cases of this rare disease[J]. Eur J Obstet Gynecol Reprod Biol, 2008, 138(2): 217-21. doi: 10.1016/j.ejogrb.2007.08.002
    [24] Bousquet G, Marsiglia H. Phyllodes tumor of the breast[J]. Int J Radiat Oncol Biol Phys, 2008, 70(2): 492-500. doi: 10.1016/j.ijrobp.2007.06.059
    [25] Spitaleri G, Toesca A, Botteri EA, et al. Breast phyllodes tumor: A review of literature and a single center retrospective series analysis[J]. Crit Rev Oncol Hematol, 2013, 88(2): 427-36. doi: 10.1016/j.critrevonc.2013.06.005
  • 加载中
图(1)
计量
  • 文章访问数:  746
  • HTML全文浏览量:  348
  • PDF下载量:  4
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-02-09
  • 刊出日期:  2018-04-01

目录

    /

    返回文章
    返回

    关于《分子影像学杂志》变更刊期通知

    各位专家、作者、读者:

    为了缩短出版时滞,促进科研成果的快速传播,我刊自2024年1月起,刊期由双月刊变更为月刊。本刊主要栏目有:基础研究、临床研究、技术方法、综述等。

    感谢各位专家、作者、读者长期以来对我刊的支持与厚爱!

    南方医科大学学报编辑部

    《分子影像学杂志》

    2023年12月27日